Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-HT4 or 5-HT6 receptors following antipsychotic administration

[1]  R. Idzerda,et al.  Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Svenningsson,et al.  Dopamine–Adenosine Interactions in the Striatum and the Globus Pallidus: Inhibition of Striatopallidal Neurons through Either D2 or A2A Receptors Enhances D1Receptor-Mediated Effects on c-fos Expression , 1997, The Journal of Neuroscience.

[3]  N. Yokotani,et al.  The comparative effects of haloperidol, (−)-sulpiride, and SCH23390 on c-fos and c-jun mRNA expressions, and AP-1 DNA binding activity , 1997, European Neuropsychopharmacology.

[4]  S. Augood,et al.  Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum: a detailed cellular co-expression study , 1996, Neuroscience.

[5]  R. Guieu,et al.  Adenosine and the nervous system: clinical implications. , 1996, Clinical neuropharmacology.

[6]  B. Fredholm,et al.  Pharmacology of adenosine A2A receptors. , 1996, Trends in pharmacological sciences.

[7]  D. Dorsa,et al.  Colocalization of serotonin receptor subtypes 5‐HT2A, 5‐HT2C, and 5‐HT6 with neuropeptides in rat striatum , 1996, The Journal of comparative neurology.

[8]  M. Egan,et al.  The Effects of Acute and Chronic Haloperidol Treatment on Dopamine Release Mediated by the Medial Forebrain Bundle in the Striatum and Nucleus Accumbens , 1996, Neuropsychopharmacology.

[9]  R. Corbett,et al.  Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia. , 1996, European journal of pharmacology.

[10]  R. J. Boegman,et al.  Involvement of adenosine and glutamate receptors in the induction of c‐fos in the striatum by haloperidol , 1996, Synapse.

[11]  S. Ahlénius,et al.  Antagonism by the 5-HT2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat. , 1995, European journal of pharmacology.

[12]  P. Roy-Byrne,et al.  Effect of muscimol on haloperidol-induced alteration of neurotensin gene expression in the striatum and nucleus accumbens in the rat , 1995, Brain Research.

[13]  B. Evers,et al.  Characterization of promoter elements required for cell-specific expression of the neurotensin/neuromedin N gene in a human endocrine cell line , 1995, Molecular and cellular biology.

[14]  H. Kao,et al.  The 5‐HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. , 1995, The EMBO journal.

[15]  B. Bloch,et al.  D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum , 1995, The Journal of comparative neurology.

[16]  C. Kilts,et al.  Anatomy and Mechanisms of Neurotensin‐Dopamine Interactions in the Central Nervous System , 1995, Annals of the New York Academy of Sciences.

[17]  C. Felder.  Muscarinic acetylcholine receptors: signal transduction through multiple effectors , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  C. Konradi,et al.  Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein , 1995, Neuroscience.

[19]  D. Sibley,et al.  Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry , 1995, Neuroscience.

[20]  R. Taussig,et al.  Mammalian Membrane-bound Adenylyl Cyclases (*) , 1995, The Journal of Biological Chemistry.

[21]  U. Ungerstedt,et al.  Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia , 1994, Neuroscience.

[22]  S. Zorn,et al.  Clozapine is a potent and selective muscarinic M4 receptor agonist. , 1994, European journal of pharmacology.

[23]  H. Fibiger,et al.  Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. , 1994, The Journal of pharmacology and experimental therapeutics.

[24]  G. Reynolds,et al.  Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia , 1994, Acta psychiatrica Scandinavica. Supplementum.

[25]  M. Dragunow,et al.  Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. , 1994, Brain research. Molecular brain research.

[26]  G. Wooten,et al.  Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons , 1993, Brain Research.

[27]  T. V. Nguyen,et al.  The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Jacobson,et al.  8‐(3‐Chlorostyryl)caffeine (CSC) is a selective A2‐adenosine antagonist in vitro and in vivo , 1993, FEBS letters.

[29]  D. Dorsa,et al.  Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Sibley,et al.  Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. , 1993, Molecular pharmacology.

[31]  B. M. Cohen,et al.  Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. Karoum,et al.  Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol , 1992, British journal of pharmacology.

[33]  DM Dorsa,et al.  Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  E. Richelson,et al.  Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. , 1992, The Journal of pharmacology and experimental therapeutics.

[35]  E. Borrelli,et al.  Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Baldessarini,et al.  Clozapine. A novel antipsychotic agent. , 1991, The New England journal of medicine.

[37]  D. Dorsa,et al.  Haloperidol rapidly increases the number of neurotensin mRNA-expressing neurons in neostriatum of the rat brain , 1991, Brain Research.

[38]  S. Ferré,et al.  Is experimental catalepsy properly measured? , 1990, Pharmacology Biochemistry and Behavior.

[39]  M. Miller,et al.  Distribution of neurotensin/neuromedin N mRNA in rat forebrain: unexpected abundance in hippocampus and subiculum. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Giordano,et al.  The catalepsy test: its ups and downs. , 1988, Behavioral neuroscience.

[41]  P. Sanberg,et al.  Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy , 1988, Brain Research.

[42]  R. Hurd,et al.  INDUCTION OF CATALEPSY BY CENTRAL NERVOUS SYSTEM ADMINISTRATION OF NEUROTENSIN * , 1982, Annals of the New York Academy of Sciences.

[43]  C. Nemeroff,et al.  Neurotensin induces catalepsy in mice , 1982, Neuropharmacology.

[44]  S. Govoni,et al.  Increase of neurotensin content elicited by neuroleptics in nucleus accumbens. , 1980, The Journal of pharmacology and experimental therapeutics.

[45]  L. Tune,et al.  Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. , 1980, Archives of general psychiatry.

[46]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[47]  Cochran Bh.  Regulation of immediate early gene expression. , 1993 .

[48]  U. Schwabe,et al.  Adenosine receptors in the central nervous system. , 1991, Journal of neural transmission. Supplementum.

[49]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[50]  C. Nemeroff.  Neurotensin: perchance an endogenous neuroleptic? , 1980, Biological psychiatry.